Promomed Public Joint Stock Company was established on December 26, 1995.
The Company s main activities are production, development and wholesale of pharmaceutical products.
The Company s legal address is at Moscow, Mira Avenue, 13 building 1, floor/room 2/5.
Since July 5, 2024 the Company s shares have been listed on Moscow Exchange under ticket PRMD.
History overview:
1995: established,
2021: changed name into Joint Stock Company,
2024: changed name into Public Joint Stock Company and listed on MOEX.

Headquarters
Prospekt Mira, 13, Building 1
Moscow; Moscow; Postal Code: 129090

Contact Details: Purchase the Promomed PAO (Промомед ПАО) report to view the information.

Website: http://promomed.ru

Basic Information

Outstanding Shares:

Purchase the Promomed PAO (Промомед ПАО) report to view the information.

Financial Auditors:

Purchase the Promomed PAO (Промомед ПАО) report to view the information.

Incorporation Date:

February 22, 1995

Key Executives

Purchase this report to view the information.

Chief Executive Officer

Ownership Details

Purchase this report to view the information.

Subsidiaries

Llc Promomed Dm

100%

Llc Promomed Rus

99.99%

Promomed Reduxin Holdings (Cyprus) Limited (Cyprus)

99.9%

Company Performance

Financial values in the chart are available after Promomed PAO (Промомед ПАО) report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.

Operating Profit/Loss (EBIT)

66.29%▲

EBITDA

66.44%▲

Net Profit/Loss for the Period

N/A

Total Assets

-69.72%▼

Total Equity

-69.74%▼

Return on Equity (ROE)

N/A

Quick Ratio

10.9%▲

Cash Ratio

0.01%▲

Promomed PAO (Промомед ПАО) (Russia)

Similar companies